C07D 243/12
1,5-benzodiazepines
Official title: 1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
C07D243/12 (1,5-benzodiazepines) appears on 159 US grants and 129 published applications in this corpus.
Search patents in C07D- Granted patents
- 159
- Published applications
- 129
- Assignees
- 88
- Inventors
- 438
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 2 | 0 |
| 1978 | 8 | 0 |
| 1979 | 6 | 0 |
| 1980 | 3 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 9 | 0 |
| 1998 | 5 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 0 |
| 2002 | 5 | 4 |
| 2003 | 6 | 8 |
| 2004 | 4 | 6 |
| 2005 | 7 | 7 |
| 2006 | 6 | 6 |
| 2007 | 7 | 5 |
| 2008 | 7 | 14 |
| 2009 | 2 | 3 |
| 2010 | 5 | 11 |
| 2011 | 1 | 5 |
| 2012 | 1 | 7 |
| 2013 | 2 | 3 |
| 2014 | 4 | 6 |
| 2015 | 7 | 6 |
| 2016 | 2 | 6 |
| 2017 | 2 | 6 |
| 2018 | 7 | 7 |
| 2019 | 5 | 4 |
| 2020 | 5 | 7 |
| 2021 | 4 | 2 |
| 2022 | 5 | 3 |
| 2023 | 0 | 1 |
| 2024 | 3 | 2 |
| 2025 | 2 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof26 May 2026US 12,637,436 B2Sanford Burnham Prebys Medical Discovery Institute
- Cholecystokinin B receptor targeting for imaging and therapy2 Dec 2025US 12,485,179 B2Purdue Research Foundation
- Compounds for the treatment of Alzheimer's disease29 Jul 2025US 12,371,409 B2The Governors of the University of Alberta
- Inhibitors of EGFR and methods of use thereof10 Dec 2024US 12,161,649 B2Dana-Farber Cancer Institute, Inc.
- P2X4 receptor antagonist15 Oct 2024US 12,116,351 B2Nippon Chemiphar Co., Ltd.
- P2x4 receptor antagonist19 Dec 2024US 2024/0417379 A1Nippon Chemiphar Co., Ltd.
- Compounds for the Treatment of Alzheimer's Disease14 Nov 2024US 2024/0376059 A1The Governors of the University of Alberta
- Metabotropic glutamate receptor negative allosteric modulators (nams) and uses thereof13 Apr 2023US 2023/0113588 A1Sanford Burnham Prebys Medical Discovery Institute
- P2x4 receptor antagonist1 Dec 2022US 2022/0380322 A1Nippon Chemiphar Co., Ltd.
- Cholecystokinin b receptor targeting for imaging and therapy1 Sep 2022US 2022/0273803 A1Purdue Research Foundation
Most cited
By later US patents
- Condensed heterocyclic compounds154US 5,037,825 AHoffmann-La Roche Inc. · 1991
- Asthma and allergic inflammation modulators81US 7,541,383 B2Amgen Inc. · 2009
- Inhibitors of interleukin-1β converting enzyme55US 6,420,522 B1Vertex Pharmaceuticals Incorporated · 2002
- Hetero-benzazepine derivatives and their pharmaceutical use53US 4,477,464 ACiba-Geigy Corporation · 1984
- Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds50US 6,509,331 B1Elan Pharmaceuticals, Inc. · 2003